UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Strategy Inc
MSTR
|
+$1.21B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$855M |
| 3 |
Microsoft
MSFT
|
+$810M |
| 4 |
Advanced Micro Devices
AMD
|
+$805M |
| 5 |
Boeing
BA
|
+$739M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$561M |
| 2 |
Amneal Pharmaceuticals
AMRX
|
+$169M |
| 3 |
Eli Lilly
LLY
|
+$161M |
| 4 |
Unity
U
|
+$158M |
| 5 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$127M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.49% |
| 2 | Financials | 9.06% |
| 3 | Consumer Discretionary | 7.01% |
| 4 | Healthcare | 6.25% |
| 5 | Industrials | 6.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
IMOS
6351
ChipMOS TECHNOLOGIES
IMOS
$1.83B
| $230K | ﹤0.01% |
12,228
-4,359
| -26% | -$90.5K |
|
6352
Orange County Bancorp
OBT
$518M
| $230K | ﹤0.01% |
8,284
+772
| +10% | +$22.2K |
|
6353
Rigel Pharmaceuticals
RIGL
$750M
| $230K | ﹤0.01% |
13,667
+4,491
| +49% | +$86.1K |
|
|
JF
6354
J and Friends Holdings
JF
$17.7M
| $230K | ﹤0.01% |
255,189
-13,326
| -5% | -$12.7K |
|
|
CKPT
6355
DELISTED
Checkpoint Therapeutics
CKPT
| $230K | ﹤0.01% |
71,766
+66,488
| +1,260% | +$225K |
|
|
VGI
6356
Virtus Global Multi-Sector Income Fund
VGI
$83.7M
| $229K | ﹤0.01% |
29,941
+12,677
| +73% | +$101K |
|
6357
PrimeEnergy Resources
PNRG
$298M
| $228K | ﹤0.01% |
1,040
+213
| +26% | +$38.5K |
|
|
CANG
6358
Cango Inc
CANG
$68.5M
| $228K | ﹤0.01% |
5,179
+5,025
| +3,263% | +$173K |
|
6359
Sonida Senior Living
SNDA
$1.91B
| $227K | ﹤0.01% |
9,849
+5,601
| +132% | +$138K |
|
|
NVX
6360
NOVONIX
NVX
$102M
| $227K | ﹤0.01% |
126,200
+124,215
| +6,258% | +$241K |
|
6361
Regis Corp
RGS
$70.2M
| $226K | ﹤0.01% |
9,548
+6,281
| +192% | +$149K |
|
6362
Nuveen Arizona Quality Municipal Income Fund
NAZ
$158M
| $226K | ﹤0.01% |
19,843
+16,289
| +458% | +$194K |
|
6363
CALL
Packaging Corp of America
PKG
$22.8B
| $225K | ﹤0.01% |
1,000
-2,500
| -71% | -$578K |
|
6364
State Street SPDR Russell 1000 Low Volatility Focus ETF
ONEV
$308M
| $225K | ﹤0.01% |
1,794
-250
| -12% | -$32.5K |
|
6365
CALL
Cencora
COR
$61.2B
| $225K | ﹤0.01% |
1,000
-54,000
| -98% | -$12.7M |
|
6366
Simplify Health Care ETF
PINK
$388M
| $225K | ﹤0.01% |
7,574
-4,705
| -38% | -$148K |
|
6367
Bridgford Foods
BRID
$56.5M
| $224K | ﹤0.01% |
20,833
+19,690
| +1,723% | +$186K |
|
6368
Tredegar Corp
TG
$310M
| $224K | ﹤0.01% |
29,153
+14,896
| +104% | +$113K |
|
6369
Donegal Group Class A
DGICA
$714M
| $224K | ﹤0.01% |
14,472
+771
| +6% | +$12K |
|
6370
Alector
ALEC
$199M
| $223K | ﹤0.01% |
118,110
+1,158
| +1% | +$4.36K |
|
6371
ProShares Nasdaq-100 Dorsey Wright Momentum ETF
QQQA
$69.8M
| $222K | ﹤0.01% |
4,883
+4,582
| +1,522% | +$210K |
|
|
ADVM
6372
DELISTED
Adverum Biotechnologies
ADVM
| $222K | ﹤0.01% |
47,596
+35,188
| +284% | +$237K |
|
|
GREK
6373
Global X MSCI Greece ETF
GREK
$316M
| $221K | ﹤0.01% |
5,707
-233
| -4% | -$9.39K |
|
6374
Crawford & Co Class A
CRD.A
$669M
| $221K | ﹤0.01% |
19,115
+9,944
| +108% | +$114K |
|
6375
ETC 6 Meridian Low Beta Equity ETF
SIXL
$198M
| $221K | ﹤0.01% |
+5,921
| New | +$224K |
|
Similar funds
UBS Group's Q4 2024 Portfolio in Review
As of Q4 2024, UBS Group held 10,816 positions worth $541B, up 18% from $459B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
UBS Group deployed $80.6B of net new capital in Q4 2024, opening 1,382 new positions and adding to 6,044 existing holdings. Its largest new stake was Primo Brands: 1,234,826 shares worth $38M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was UnitedHealth, an estimated $561M trimmed.
- UBS Group's largest Q4 2024 buy was Primo Brands: 1,234,826 shares worth $38M.
- UBS Group added most to Strategy Inc in Q4 2024, an estimated $1.21B increase.
- UBS Group's biggest Q4 2024 reduction was UnitedHealth, cutting an estimated $561M.
- UBS Group fully exited CATALENT, INC. in Q4 2024, selling an estimated $86M.
- UBS Group's ten largest holdings make up 16% of its $541B portfolio in Q4 2024.
- UBS Group opened 1,382 new positions and closed 943 in Q4 2024.
- UBS Group's portfolio value rose 18% quarter-over-quarter to $541B.
Based on UBS Group's 13F filing for Q4 2024, filed 14 Feb 2025.